CN103160578B - Egfr基因专用量子点检测试剂盒 - Google Patents
Egfr基因专用量子点检测试剂盒 Download PDFInfo
- Publication number
- CN103160578B CN103160578B CN201310053479.0A CN201310053479A CN103160578B CN 103160578 B CN103160578 B CN 103160578B CN 201310053479 A CN201310053479 A CN 201310053479A CN 103160578 B CN103160578 B CN 103160578B
- Authority
- CN
- China
- Prior art keywords
- quantum dot
- egfr
- probe
- acid
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002096 quantum dot Substances 0.000 title claims abstract description 78
- 238000001514 detection method Methods 0.000 title claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 title abstract description 8
- 102000001301 EGF receptor Human genes 0.000 title abstract 5
- 108060006698 EGF receptor Proteins 0.000 title abstract 5
- 239000000523 sample Substances 0.000 claims abstract description 48
- 108700021358 erbB-1 Genes Proteins 0.000 claims abstract description 41
- 101150039808 Egfr gene Proteins 0.000 claims abstract description 37
- 108020004414 DNA Proteins 0.000 claims abstract description 22
- 210000002230 centromere Anatomy 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 20
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 15
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004584 polyacrylic acid Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910004613 CdTe Inorganic materials 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 239000002953 phosphate buffered saline Substances 0.000 claims description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 10
- 229940098773 bovine serum albumin Drugs 0.000 claims description 10
- 238000001212 derivatisation Methods 0.000 claims description 10
- 239000010695 polyglycol Substances 0.000 claims description 10
- 229920000151 polyglycol Polymers 0.000 claims description 10
- 239000000872 buffer Substances 0.000 claims description 9
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 8
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 8
- 238000013467 fragmentation Methods 0.000 claims description 8
- 238000006062 fragmentation reaction Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 230000009870 specific binding Effects 0.000 claims description 6
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 5
- 210000000349 chromosome Anatomy 0.000 claims description 5
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 5
- 150000008104 phosphatidylethanolamines Chemical group 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- WOXXJEVNDJOOLV-UHFFFAOYSA-N ethenyl-tris(2-methoxyethoxy)silane Chemical compound COCCO[Si](OCCOC)(OCCOC)C=C WOXXJEVNDJOOLV-UHFFFAOYSA-N 0.000 claims description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 150000003904 phospholipids Chemical class 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- CPUDPFPXCZDNGI-UHFFFAOYSA-N triethoxy(methyl)silane Chemical compound CCO[Si](C)(OCC)OCC CPUDPFPXCZDNGI-UHFFFAOYSA-N 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 claims description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000010353 genetic engineering Methods 0.000 claims description 2
- 239000013612 plasmid Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 20
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 239000002077 nanosphere Substances 0.000 abstract description 5
- -1 glycol derivative phospholipid Chemical class 0.000 abstract description 4
- 102000053602 DNA Human genes 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 108020003215 DNA Probes Proteins 0.000 abstract 1
- 239000003298 DNA probe Substances 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 abstract 1
- DCPMPXBYPZGNDC-UHFFFAOYSA-N hydron;methanediimine;chloride Chemical compound Cl.N=C=N DCPMPXBYPZGNDC-UHFFFAOYSA-N 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 238000006884 silylation reaction Methods 0.000 abstract 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 23
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 23
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 23
- 210000001519 tissue Anatomy 0.000 description 10
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 7
- 239000011805 ball Substances 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 201000005202 lung cancer Diseases 0.000 description 6
- 208000020816 lung neoplasm Diseases 0.000 description 6
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229910004298 SiO 2 Inorganic materials 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 229960001701 chloroform Drugs 0.000 description 3
- 239000006059 cover glass Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000005357 flat glass Substances 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000011807 nanoball Substances 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000155 isotopic effect Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 229940088872 Apoptosis inhibitor Drugs 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229910000530 Gallium indium arsenide Inorganic materials 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 229910000673 Indium arsenide Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000158 apoptosis inhibitor Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 210000002415 kinetochore Anatomy 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- WHPMALGCHJRYKZ-UHFFFAOYSA-N pentanedial Chemical compound O=CCCCC=O.O=CCCCC=O WHPMALGCHJRYKZ-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000004054 semiconductor nanocrystal Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- ACTRVOBWPAIOHC-UHFFFAOYSA-N succimer Chemical compound OC(=O)C(S)C(S)C(O)=O ACTRVOBWPAIOHC-UHFFFAOYSA-N 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 230000004862 vasculogenesis Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310053479.0A CN103160578B (zh) | 2013-02-19 | 2013-02-19 | Egfr基因专用量子点检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310053479.0A CN103160578B (zh) | 2013-02-19 | 2013-02-19 | Egfr基因专用量子点检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103160578A CN103160578A (zh) | 2013-06-19 |
CN103160578B true CN103160578B (zh) | 2015-01-28 |
Family
ID=48584112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310053479.0A Expired - Fee Related CN103160578B (zh) | 2013-02-19 | 2013-02-19 | Egfr基因专用量子点检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103160578B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104561357A (zh) * | 2015-01-30 | 2015-04-29 | 益善生物技术股份有限公司 | Egfr基因扩增检测探针、试剂盒以及方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104232761A (zh) * | 2014-08-27 | 2014-12-24 | 武汉凯吉盈科技有限公司 | 基因全片段快速测序方法 |
CN105483257A (zh) * | 2015-12-30 | 2016-04-13 | 广州安必平医药科技股份有限公司 | Egfr基因检测探针及其制备方法和试剂盒 |
CN105603109A (zh) * | 2016-03-25 | 2016-05-25 | 苏州达麦迪生物医学科技有限公司 | 一种单通道下检测bcr/abl基因融合的探针标记方法 |
CN105803063A (zh) * | 2016-04-25 | 2016-07-27 | 苏州达麦迪生物医学科技有限公司 | 一种单通道下检测eml4/alk基因融合的探针标记方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101876659A (zh) * | 2010-06-29 | 2010-11-03 | 同济大学 | 用于检测肿瘤的量子点试剂盒 |
CN101935703A (zh) * | 2010-08-27 | 2011-01-05 | 中国人民解放军第三军医大学第一附属医院 | 肠出血性大肠杆菌o157:h7多色量子点快速检测试剂盒及其检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101899504B (zh) * | 2010-05-11 | 2014-12-10 | 合肥艾迪康临床检验所有限公司 | 用于检测egfr基因拷贝数和7号染色体倍性的试剂 |
-
2013
- 2013-02-19 CN CN201310053479.0A patent/CN103160578B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101876659A (zh) * | 2010-06-29 | 2010-11-03 | 同济大学 | 用于检测肿瘤的量子点试剂盒 |
CN101935703A (zh) * | 2010-08-27 | 2011-01-05 | 中国人民解放军第三军医大学第一附属医院 | 肠出血性大肠杆菌o157:h7多色量子点快速检测试剂盒及其检测方法 |
Non-Patent Citations (1)
Title |
---|
EGFR基因突变及其检测方法的研究进展;高云等;《分子诊断与治疗杂志》;20110131;第3卷(第1期);51-57 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104561357A (zh) * | 2015-01-30 | 2015-04-29 | 益善生物技术股份有限公司 | Egfr基因扩增检测探针、试剂盒以及方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103160578A (zh) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103160578B (zh) | Egfr基因专用量子点检测试剂盒 | |
Yi et al. | Nanoscale zeolitic imidazolate framework-8 for ratiometric fluorescence imaging of microRNA in living cells | |
Lin et al. | Recent advances in autofluorescence-free biosensing and bioimaging based on persistent luminescence nanoparticles | |
Kamimura et al. | Design of poly (ethylene glycol)/streptavidin coimmobilized upconversion nanophosphors and their application to fluorescence biolabeling | |
Kamiya et al. | An enzymatically activated fluorescence probe for targeted tumor imaging | |
Clark et al. | Optical nanosensors for chemical analysis inside single living cells. 1. Fabrication, characterization, and methods for intracellular delivery of PEBBLE sensors | |
Wang et al. | Aptamer-functionalized polydiacetylene liposomes act as a fluorescent sensor for sensitive detection of MUC1 and targeted imaging of cancer cells | |
CN101876659B (zh) | 用于检测肿瘤的量子点试剂盒 | |
CN102220128B (zh) | 一种氨基化法β-环糊精修饰的低毒性功能化量子点及其制备方法 | |
Zhang et al. | Design and synthesis of near-infrared fluorescence-enhancement probes for the cancer-specific enzyme hNQO1 | |
Fan et al. | ALP-activated chemiluminescence PDT nano-platform for liver cancer-specific theranostics | |
CN106957908A (zh) | miRNA和/或具有核酸适配体的靶标分子的检测方法及检测探针 | |
CN108760704A (zh) | 一种基于回音壁模式的单细胞内物质检测方法 | |
Zhao et al. | Autoluminescence-free prostate-specific antigen detection by persistent luminous nanorods and Au@ Ag@ SiO2 nanoparticles | |
CN101806795A (zh) | 一种肿瘤靶向性的功能化量子点及其制备方法 | |
CN102206487B (zh) | 一种羧基化法β-环糊精修饰的低毒性功能化量子点及其制备方法 | |
CN104878009A (zh) | 基于长链非编码rna afap1-as1的干扰制剂及其应用方法 | |
WO2023284134A1 (zh) | 一种细胞核靶向上转换荧光探针及其制备方法和应用 | |
Wang et al. | A red fluorescent probe for ribonucleic acid (RNA) detection, cancer cell tracing and tumor growth monitoring | |
Xue et al. | Design strategy of optical probes for tumor hypoxia imaging | |
Yuan et al. | Rational Fabrication and Biomedical Application of Biomolecule‐Conjugated AIEgens through Click Reaction | |
Al-Batran et al. | Three-dimensional in vitro cocultivation of lung carcinoma cells with human bronchial organ culture as a model for bronchial carcinoma | |
CN109453393A (zh) | 制备超小荧光二氧化硅纳米颗粒的方法 | |
Jiang et al. | A near-infrared cationic fluorescent probe based on thieno [3, 2-b] thiophene for RNA imaging and long-term cellular tracing | |
CN109045304A (zh) | 一种携带Polymerase I抑制剂的核仁靶向纳米载体及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SUZHOU DMD BIO-MEDICAL CO., LTD. Free format text: FORMER NAME: SUZHOU ZHONGSHENG DAMAIDI MOLECULE DIAGNOSTICS TECHNOLOGY CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 215000, room 1, building 8, 501-503 Jinfeng Road, Jiangsu, Suzhou Patentee after: SUZHOU DMD BIOMED Ltd. Address before: 215000, room 1, building 8, 501-503 Jinfeng Road, Jiangsu, Suzhou Patentee before: SUZHOU ZHONGSHENG DAMAIDI MOLECULE DIAGNOSTICS TECHNOLOGY Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150128 |
|
CF01 | Termination of patent right due to non-payment of annual fee |